Overview of EGFR-Mutant Advanced NSCLC

Opinion
Video

Panelists discuss how advanced EGFR-mutant non-small cell lung cancer (NSCLC) requires careful molecular testing and staging for optimal targeted therapy selection, with particular attention to patient demographics and presentation patterns.

Recent Videos
2 experts in this video
2 experts in this video
2 experts in this video
2 experts in this video